Informations sur le produit
- (+)-Tbz
- (+)-Tetrabenazine
- (3R,11BR)-9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one
- (3R,11bR)-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one
- (3R,11bR)-TBZ
- (3R,11bR)-Tetrabenazine
(3R,11bR)-Tetrabenazine-d3 is a racemic form of tetrabenazine that can be used as a molecular imaging agent. It is synthesized by reacting dihydroisoquinoline with hexane in the presence of malonate and an asymmetric synthesis. The product is purified by crystallization with methanol and analyzed using analytical methods such as gas chromatography or mass spectrometry. (3R,11bR)-Tetrabenazine-d3 has been shown to be effective for the treatment of Parkinson's disease and hyperkinetic movement disorders. It is also used to treat neuroleptic malignant syndrome and other conditions caused by dopamine-producing cells in the brain. Tetrabenazine binds to dopamine receptors on cells in the brain, blocking the effects of dopamine and reducing muscle rigidity, tremors, restlessness, and slowing movements. This drug also has a stereogenic center which means it
Propriétés chimiques
Question d’ordre technique sur : 3D-BRB01683 (3R,11bR)-Tetrabenazine-d3
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
